Respiration during chronic inhibition of renal carbonic anhydrase: further observations on pharmacology of 2-benzenesulfonamido-1,3, 4-thiadiazole-5-sulfonamide (CL 11,366), acetazolamide and methazolamide.
D000086:Acetazolamide / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D004285:Dogs; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D009132:Muscles / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D013449:Sulfonamides / Q000494:pharmacology*
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D000086:Acetazolamide